Sian Ellard Selected Research

Mason-Type Diabetes

1/2016	Characteristics of maturity onset diabetes of the young in a large diabetes center.
7/2015	Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.
10/2013	Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth.
9/2013	Maturity onset diabetes of the young: identification and diagnosis.
5/2013	Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
9/2011	Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes.
8/2011	High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
5/2011	Discovery of a novel site regulating glucokinase activity following characterization of a new mutation causing hyperinsulinemic hypoglycemia in humans.
2/2011	Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
11/2009	Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sian Ellard Research Topics

Disease

37	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2002
28	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 01/2003
26	Hyperglycemia 01/2021 - 12/2002
21	Congenital Hyperinsulinism 01/2020 - 07/2008
20	Diabetes Mellitus 01/2022 - 12/2002
20	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2020 - 01/2003
18	Mason-Type Diabetes 01/2016 - 12/2002
9	Hyperinsulinism (Hyperinsulinemia) 02/2019 - 05/2004
9	Permanent Neonatal Diabetes Mellitus 03/2014 - 04/2007
6	Insulin Resistance 03/2018 - 10/2003
6	Cysts 02/2015 - 10/2001
5	Ketosis 08/2018 - 04/2004
5	Acromegaly 09/2017 - 11/2012
4	Seizures (Absence Seizure) 10/2021 - 07/2009
4	Neoplasms (Cancer) 12/2020 - 07/2011
4	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2020 - 09/2007
4	Disease Progression 01/2018 - 12/2016
3	Neurodevelopmental Disorders 01/2022 - 01/2021
3	Mitochondrial Diseases (Mitochondrial Disease) 10/2021 - 01/2019
3	Familial Isolated Pituitary Adenoma 01/2020 - 08/2010
3	Liver Diseases (Liver Disease) 01/2020 - 10/2014
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020 - 07/2011
3	Pituitary Neoplasms (Pituitary Adenoma) 01/2018 - 01/2016
3	3-Hydroxyacyl-CoA Dehydrogenase Deficiency 06/2015 - 07/2009
3	Megaloblastic Anemia 08/2013 - 05/2013
3	Deafness (Deaf Mutism) 08/2013 - 04/2008
2	Uniparental Disomy 07/2022 - 01/2008
2	Intellectual Disability (Idiocy) 01/2022 - 10/2021
2	Hearing Loss (Hearing Impairment) 01/2022 - 05/2013
2	Polycystic Kidney Diseases (Polycystic Kidney Disease) 12/2021 - 01/2017
2	Microcephaly 01/2021 - 10/2013
2	Birth Weight (Birth Weights) 01/2020 - 04/2008
2	Hypopituitarism (Sheehan's Syndrome) 01/2020 - 11/2010
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2020 - 01/2018
2	Insulinoma 01/2020 - 05/2015
2	Weight Gain 01/2020 - 08/2018
2	Cakut 12/2019 - 07/2008
2	Hyperplasia 01/2019 - 11/2008
2	Developmental Delay, Epilepsy, and Neonatal Diabetes 01/2018 - 09/2010
2	Lipodystrophy 01/2018 - 01/2004
2	Gigantism 09/2017 - 01/2017
2	Fanconi Syndrome (Syndrome, Fanconi) 07/2017 - 03/2014
2	Exocrine Pancreatic Insufficiency 01/2016 - 03/2013
2	Solitary Kidney 02/2015 - 04/2002
2	Kidney Diseases (Kidney Disease) 02/2015 - 12/2002
2	Hypothyroidism 12/2014 - 09/2012
2	Gestational Diabetes (Gestational Diabetes Mellitus) 06/2014 - 01/2014
2	Anemia 08/2013 - 05/2013
2	Multiple Endocrine Neoplasia Type 1 07/2011 - 03/2008

Drug/Important Bio-Agent (IBA)

53	Insulin (Novolin)FDA Link 01/2022 - 12/2002
24	GlucokinaseIBA 01/2020 - 09/2003
18	Adenosine Triphosphate (ATP)IBA 01/2020 - 11/2004
16	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 06/2005
15	KATP ChannelsIBA 01/2021 - 03/2006
13	AutoantibodiesIBA 01/2022 - 09/2007
13	Diazoxide (Hyperstat)FDA Link 02/2019 - 06/2008
12	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2002
10	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 03/2008
10	Transcription Factors (Transcription Factor)IBA 01/2018 - 05/2004
10	Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA 05/2013 - 12/2002
9	C-PeptideIBA 12/2020 - 11/2008
9	Hepatocyte Nuclear Factor 1-betaIBA 07/2008 - 10/2001
7	Hepatocyte Nuclear FactorsIBA 01/2020 - 05/2003
7	aryl hydrocarbon receptor-interacting proteinIBA 01/2020 - 08/2010
6	Blood Glucose (Blood Sugar)IBA 01/2020 - 06/2005
6	EnzymesIBA 01/2018 - 06/2005
5	Biomarkers (Surrogate Marker)IBA 01/2018 - 05/2012
5	Thiamine (Aneurin)FDA Link 08/2013 - 06/2012
5	Sulfonylurea ReceptorsIBA 06/2011 - 03/2006
4	Glyburide (Glibenclamide)FDA LinkGeneric 01/2021 - 03/2005
4	Octreotide (Sandostatin)FDA LinkGeneric 01/2018 - 11/2012
4	Sirolimus (Rapamycin)FDA Link 01/2018 - 03/2014
4	PotassiumIBA 03/2014 - 11/2007
3	Metformin (Glucophage)FDA LinkGeneric 12/2018 - 10/2003
3	Hepatocyte Nuclear Factor 1IBA 06/2012 - 02/2011
2	ElementsIBA 07/2022 - 12/2009
2	Transfer RNA (tRNA)IBA 01/2022 - 10/2013
2	phosphomannomutaseIBA 12/2021 - 01/2017
2	Kainic Acid Receptors (Kainate Receptor)IBA 11/2021 - 01/2021
2	P-2 (P 2)IBA 01/2020 - 10/2016
2	MagnesiumIBA 09/2019 - 05/2009
2	ElectrolytesIBA 09/2019 - 02/2015
2	HLA-DR Antigens (HLA-DR)IBA 01/2018 - 05/2017
2	Amino Acids FDA Link 09/2017 - 05/2007
2	Hypoglycemic Agents (Hypoglycemics)IBA 07/2017 - 07/2009
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2016 - 10/2014
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 11/2008
2	Hormones (Hormone)IBA 01/2015 - 11/2010
2	Pharmaceutical PreparationsIBA 01/2014 - 09/2003
2	NFI Transcription FactorsIBA 05/2013 - 09/2006
2	Nonsense Codon (Nonsense Mutation)IBA 05/2013 - 11/2012
2	Hepatocyte Nuclear Factor 4IBA 06/2012 - 02/2011
2	AntibodiesIBA 09/2011 - 11/2008
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 09/2011 - 05/2011

Therapy/Procedure

21	Therapeutics 01/2020 - 03/2005
6	Glycemic Control 01/2021 - 11/2003
5	Pancreatectomy 06/2016 - 01/2010
2	Radiotherapy 01/2020 - 11/2012
2	Enzyme Replacement Therapy 08/2018 - 03/2013
2	Injections 01/2018 - 02/2008